Foghorn Therapeutics (FHTX) Stock Chart & Stock Price History → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free FHTX Stock Alerts $5.81 +0.52 (+9.83%) (As of 12:47 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Foghorn Therapeutics Stock Price Performance5 Day Performance-4.86%1 Month Performance-12.27%3 Month Performance-18.87%6 Month Performance+39.95%Year-To-Date Performance-17.98%1 Year Performance-17.34% Receive FHTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. FHTX Stock Chart for Thursday, May, 16, 2024 FHTX Chart by TradingView Foghorn Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$5.67$5.29-6.70%$5.95$5.2279,389 shs$225.30 million05/14/2024$5.67$5.67$5.92$5.3385,904 shs$241.49 million05/13/2024$5.56$5.67+1.98%$6.07$5.5359,781 shs$241.49 million05/10/2024$5.94$5.56-6.40%$6.01$5.11146,081 shs$236.69 million05/09/2024$5.98$5.94-0.67%$6.50$5.8882,536 shs$252.87 million05/08/2024$5.63$5.98+6.22%$5.98$5.5155,696 shs$254.57 million Get the Latest News and Ratings for FHTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$5.83$5.63-3.43%$6.03$5.6258,265 shs$239.67 million05/06/2024$5.99$5.83-2.67%$6.29$5.8330,420 shs$248.18 million05/03/2024$6.11$5.99-1.96%$6.52$5.8248,320 shs$254.99 million05/02/2024$5.86$6.11+4.27%$6.35$5.8768,642 shs$260.10 million05/01/2024$5.46$5.86+7.33%$6.25$5.4860,554 shs$249.46 million04/30/2024$5.73$5.46-4.71%$5.68$5.4428,866 shs$232.43 million04/29/2024$5.49$5.73+4.37%$5.90$5.6116,461 shs$243.93 million04/26/2024$5.23$5.49+4.97%$5.55$5.1635,367 shs$233.71 million04/25/2024$5.21$5.23+0.38%$5.31$4.8048,749 shs$222.64 million04/24/2024$5.16$5.21+0.97%$5.62$5.15111,112 shs$221.79 million04/23/2024$5.05$5.16+2.18%$5.38$5.0945,759 shs$219.66 million04/22/2024$5.30$5.05-4.72%$5.40$4.9677,555 shs$214.98 million04/19/2024$5.53$5.30-4.16%$5.94$5.14118,158 shs$225.62 million04/18/2024$5.78$5.53-4.33%$5.89$5.51127,287 shs$235.41 million04/17/2024$6.03$5.78-4.15%$6.74$5.75135,861 shs$246.03 million04/16/2024$6.39$6.03-5.63%$6.21$5.8387,006 shs$256.70 million04/15/2024$7.42$6.39-13.88%$7.45$6.2768,342 shs$272.02 million04/12/2024$8.00$7.42-7.25%$7.99$6.9995,419 shs$315.87 million04/11/2024$7.26$8.00+10.19%$8.05$7.02123,981 shs$340.56 million04/10/2024$7.48$7.26-2.94%$7.89$6.8671,462 shs$309.06 million04/09/2024$7.17$7.48+4.32%$7.69$7.2651,806 shs$318.42 million04/08/2024$7.10$7.17+0.99%$7.42$7.0061,284 shs$305.23 million04/05/2024$7.05$7.10+0.71%$7.26$6.6239,505 shs$302.25 million04/04/2024$7.21$7.05-2.22%$7.55$6.8193,886 shs$300.12 million04/03/2024$7.00$7.21+3.00%$7.63$7.0083,760 shs$306.93 million04/02/2024$7.13$7.00-1.82%$7.15$6.8142,548 shs$297.99 million04/01/2024$6.71$7.13+6.26%$7.44$6.2793,903 shs$303.52 million03/29/2024$6.71$6.71$6.76$6.2668,593 shs$285.65 million03/28/2024$6.28$6.71+6.85%$6.76$6.2668,593 shs$285.65 million03/27/2024$6.07$6.28+3.46%$6.31$6.0255,155 shs$267.34 million03/26/2024$5.94$6.07+2.19%$6.20$6.0142,901 shs$258.40 million03/25/2024$6.36$5.94-6.60%$6.66$5.8599,912 shs$252.87 million03/22/2024$6.57$6.36-3.20%$6.72$6.2192,235 shs$270.75 million03/21/2024$6.49$6.57+1.23%$7.04$6.5467,742 shs$279.69 millionLook Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here.03/20/2024$6.07$6.49+6.92%$6.57$5.9386,234 shs$276.28 million03/19/2024$5.93$6.07+2.36%$6.19$5.8746,523 shs$258.40 million03/18/2024$5.91$5.93+0.34%$6.19$5.8080,693 shs$252.44 million03/15/2024$6.05$5.91-2.31%$6.24$5.78128,368 shs$251.59 million03/14/2024$6.76$6.05-10.50%$6.73$5.8193,691 shs$257.52 million03/13/2024$6.54$6.76+3.36%$6.80$6.4844,748 shs$287.75 million03/12/2024$6.81$6.54-3.96%$7.14$6.24156,594 shs$278.41 million03/11/2024$6.59$6.81+3.34%$6.99$6.32121,281 shs$289.90 million03/08/2024$6.83$6.59-3.51%$7.25$6.4783,082 shs$278.23 million03/07/2024$6.79$6.83+0.59%$7.13$6.38121,738 shs$288.36 million03/06/2024$6.39$6.79+6.26%$7.14$6.18125,034 shs$286.67 million03/05/2024$6.79$6.39-5.89%$6.91$6.3293,752 shs$269.79 million03/04/2024$7.94$6.79-14.48%$8.16$6.78198,296 shs$286.67 million03/01/2024$7.73$7.94+2.72%$8.44$7.74132,636 shs$335.23 million02/29/2024$7.78$7.73-0.64%$8.13$7.5188,800 shs$326.36 million02/28/2024$7.20$7.78+8.06%$7.89$7.10137,640 shs$328.47 million02/27/2024$7.54$7.20-4.51%$7.79$6.72183,283 shs$303.98 million02/26/2024$5.98$7.54+26.09%$7.58$5.96163,902 shs$318.34 million02/23/2024$6.09$5.98-1.81%$6.51$5.88119,316 shs$252.48 million02/22/2024$5.97$6.09+2.01%$6.32$5.95130,243 shs$257.12 million02/21/2024$5.91$5.97+1.02%$6.22$5.80100,819 shs$252.05 million02/20/2024$6.52$5.91-9.36%$6.60$5.81126,828 shs$249.52 million02/19/2024$6.52$6.52$6.78$6.26115,300 shs$275.27 million02/16/2024$6.81$6.52-4.26%$6.78$6.26115,310 shs$275.27 million02/15/2024$6.75$6.81+0.89%$7.40$6.72221,767 shs$287.50 million Related Companies: 23andMe Stock Chart Veru Stock Chart Conduit Pharmaceuticals Stock Chart AC Immune Stock Chart Aldeyra Therapeutics Stock Chart Werewolf Therapeutics Stock Chart Emergent BioSolutions Stock Chart uniQure Stock Chart Puma Biotechnology Stock Chart Zevra Therapeutics Stock Chart Receive FHTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FHTX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Foghorn Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.